Story preview
Continue reading on the publisher site for the full article.
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
3
in the last 3 days
First reported
4 days ago
2 outlets since
Countries
2 other outlets reported this story in the last 3 days.
Danaher (DHR) has put artificial intelligence at the center of its latest move by outlining plans for an autonomous lab at Abcam that targets faster, more scalable antibody and molecular tool development. The latest autonomous lab announcement comes after a period in which Danaher’s 90-day share price return of 11.49%…
Danaher (DHR) is back in focus after RBC adjusted its view, keeping an outperform rating and raising its price objective, as investors reassess recent missteps, leadership changes, and mixed biotech and diagnostics momentum. Recent trading has been choppy for Danaher, with the share price falling 2.53% over the last…